Earnings Summary

Jin Medical International Ltd’s revenue jumped 10.33% since last year same period to $5.28Mn in the Q2 2024. On a quarterly growth basis, Jin Medical International Ltd has generated -44.83% fall in its revenue since last 3-months.

Jin Medical International Ltd’s net profit jumped 61.36% since last year same period to $0.9Mn in the Q2 2024. On a quarterly growth basis, Jin Medical International Ltd has generated -19.32% fall in its net profits since last 3-months.

Jin Medical International Ltd’s net profit margin jumped 46.25% since last year same period to 16.99% in the Q2 2024. On a quarterly growth basis, Jin Medical International Ltd has generated 46.25% jump in its net profit margins since last 3-months.

Jin Medical International Ltd’s price-to-earnings ratio after this Q2 2024 earnings stands at 125.

Jin Medical International Ltd’s earning per share (EPS) estimates for the current quarter stand at 0 - a NaN% jump from last quarter’s estimates.

Jin Medical International Ltd’s earning per share (EPS) estimates for the current year stand at 0.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Jin Medical International Ltd’s return on assets (ROA) stands at 0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Jin Medical International Ltd’s return on equity (ROE) stands at 0.11.